Several companies are recalling products due to contamination from substances such as carcinogens and glass—here’s what you should know.
Postpartum drug is a game changer, but can women afford it?
FDA approved a new subcutaneous injection to treat a certain type of early breast cancer.
FDA approved a new generic of Novartis’ Diovan (valsartan) amid a shortage of the blood pressure drug.
Nasal spray offers promise for treatment-resistant depression, but proceed with caution.
How FDA Chief Gottlieb’s resignation could impact the pharma industry.
To stave off competition from other generic makers and appease Congress, Eli Lilly is introducing a generic version of its insulin lispro injection (Humalog).
The recalls of a widely used hypertension blood drug due to carcinogenic impurities are expanding.
FDA is warning about an increased risk of death and blood clots in the lungs in patients with rheumatoid arthritis taking a specific dosage of this drug.
FDA is requiring the addition of a Black Box Warning to a gout drug that has an increased risk of death.